Wegovy vs Ozempic

Wegovy and Ozempic confuse people more than almost any pair of medications in the modern landscape. Same molecule. Same company. Different boxes. Different uses. Different doses. The questions come up constantly: can I use one instead of the other? Is one better? Why two brands of the same drug?

Here is the honest comparison, particularly with the South African context in mind.

The Comparison Table

The Same Molecule, Genuinely

Semaglutide is semaglutide. The chemistry is identical whether the box says Wegovy or Ozempic. The receptor it acts on, the half life, the side effect profile, the way it reduces appetite, the way it improves blood sugar, are all the same.

What differs is how the molecule is packaged and what doses are made available, which in turn shapes what condition it is approved to treat.

Why The Different Brand Names

When Novo Nordisk developed semaglutide, they ran two separate clinical trial programmes. One for type 2 diabetes (the SUSTAIN trials). One for weight management (the STEP trials). The diabetes programme used lower doses, typically up to 1 mg weekly. The weight management programme used higher doses, up to 2.4 mg weekly.

Regulators (FDA, EMA, SAHPRA, others) approved the medication at each dose range for each specific indication. The product was then branded differently for each use to make the indication clear and to keep the supply chains separate. Ozempic for diabetes, Wegovy for weight management.

This is unusual in pharmacy but not unique. The same molecule under different brand names with different dose strengths is how regulators distinguish indications.

The Off Label Question

For several years, particularly before Wegovy was available in South Africa, doctors prescribed Ozempic off label for weight loss. This happened globally as celebrity use of 'Ozempic' for weight loss spread. The off label use was technically legal where prescribing decisions are at the doctor's discretion, but it caused problems:

• Ozempic shortages, leaving people with diabetes without medication
• Dose limitations (1 mg max in SA, which is below the optimal weight management dose)
• Insurance and medical aid complications
• SAHPRA discomfort with widespread off label use

Now that Wegovy is available in South Africa, the off label justification has weakened considerably. The right medication for weight management is the one approved for weight management. Most prescribers and pharmacies have shifted accordingly.

Cost Comparison In South Africa

Pricing matters in this conversation because it influences which medication people end up on.

Ozempic

Has historically sat around R2,800 per month at typical doses. Stable pricing for some time. Medical aid coverage is common for type 2 diabetes (often listed as a chronic condition).

Wegovy

After Novo Nordisk's March 2026 price reductions, the lowest dose (0.25 mg) sits at around R1,873 per month. The maximum dose (2.4 mg) sits at around R3,746 per month. A second reduction was submitted shortly after the first. Pricing during the titration months (months 1-4 on the lower doses) is lower than at maintenance.

For people who would respond well at 1 mg or 1.7 mg (rather than needing the full 2.4 mg), the ongoing monthly cost can be comparable to or lower than Ozempic.

Medical aid cover for weight management is variable. Many schemes do not cover GLP-1 medications specifically for weight loss because obesity is not on the Chronic Disease List under PMB regulations. Some cover it from medical savings accounts. This is changing slowly. More on medical aid.

Side Effects Comparison

Identical. Same drug, same side effect profile. Gastrointestinal effects dominate the first weeks and after dose increases: nausea, sometimes vomiting, diarrhoea or constipation, indigestion. These usually settle. Rare but serious effects (pancreatitis, gallbladder issues, thyroid concerns) apply to both.

Efficacy: Weight Loss

This is where the dose difference shows up. Ozempic at 1 mg produces modest weight loss as a side effect (around 4-6 percent on average). Wegovy at 2.4 mg produces around 15 percent on average in trials. The difference is mostly because of dose.

If someone on Ozempic for diabetes responds well in weight terms at 1 mg, switching to Wegovy at 2.4 mg would likely produce additional weight reduction. But Ozempic remains primarily a diabetes medication, and weight is the secondary benefit there.

Efficacy: Blood Sugar

Both reduce blood sugar in people with type 2 diabetes. Ozempic, used at the dose range approved for diabetes, is the option with diabetes-specific dose flexibility in SA. Wegovy reduces HbA1c in people with type 2 diabetes too, but is not approved as a diabetes treatment in SA, so this is a secondary benefit rather than a prescribing indication.

Cardiovascular Benefit

Both have cardiovascular data, but from different trials and for different populations.

Ozempic

The SUSTAIN-6 trial in people with type 2 diabetes and cardiovascular risk showed reduction in major adverse cardiovascular events. Ozempic is registered for cardiovascular risk reduction in adults with type 2 diabetes and known heart disease.

Wegovy

The SELECT trial in people with established cardiovascular disease and BMI of 27 or more (without diabetes) showed a 20 percent reduction in major adverse cardiovascular events. Wegovy is the first weight management medication approved specifically to reduce these events.

The indications are different. Both add cardiovascular benefit. The right one depends on whether the primary issue is diabetes (Ozempic) or excess weight in someone with cardiovascular disease (Wegovy). More on Wegovy cardiovascular use.

Practical Summary For South African Patients

If your goal is weight management

Wegovy is the SAHPRA approved option. It is the right choice if you meet the BMI criteria.

If your goal is type 2 diabetes treatment

Ozempic remains a strong option for diabetes specifically. Mounjaro (tirzepatide) is another option with strong diabetes evidence.

If you have both diabetes and weight to manage

This is where the conversation gets specific. A consulting doctor weighs which is the primary issue, what dose flexibility is needed, and what cost differences mean for you.

If you currently use Ozempic for weight loss off label

Have a conversation with your treating doctor about switching to Wegovy. The dose flexibility and the regulatory clarity are both better with Wegovy.

Frequently Asked